78206-185 : Hadlima 40 mg/.8ml Subcutaneous Solution
NDC: | 78206-185 |
Labeler: | Organon LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Hadlima |
Dosage Form: | Subcutaneous Solution |
Application #: | BLA761059 |
Rev. Date: |
NDC Package Codes:
- 78206-185-01: 1 CARTON IN 1 CARTON (78206‑185‑01) / 1 VIAL IN 1 CARTON (78206‑185‑99) / .8 ML IN 1 VIAL
Active Ingredients:
- Adalimumab
Dosage Strength:
- 40 mg/.8mL
Pharmaceutical Classes:
- Antibodies
- Monoclonal [CS]
- Tumor Necrosis Factor Blocker [EPC]
- Tumor Necrosis Factor Receptor Blocking Activity [MoA]
Related Products:
Based on records with the same trade name.- 78206-183 Hadlima 40 mg/.8ml Subcutaneous Solution by Organon LLC
- 78206-184 Hadlima 40 mg/.8ml Subcutaneous Solution by Organon LLC
- 78206-186 Hadlima 40 mg/.4ml Subcutaneous Solution by Organon LLC
- 78206-187 Hadlima 40 mg/.4ml Subcutaneous Solution by Organon LLC
- 50090-6704 Hadlima 40 mg/.4ml Subcutaneous Solution by A-s Medication Solutions
- 50090-6705 Hadlima 40 mg/.8ml Subcutaneous Solution by A-s Medication Solutions
- 50090-6706 Hadlima 40 mg/.8ml Subcutaneous Solution by A-s Medication Solutions
- 50090-6707 Hadlima 40 mg/.4ml Subcutaneous Solution by A-s Medication Solutions
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 78206-184Next: 78206-186 >
Related Discussions:
Humira (adalimumab) for pain
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.